Dear Valued Stakeholders,

We are pleased to inform you that effective from April 9, 2024, key divisions of the National Medicines Regulatory Authority have relocated to a new address. This move is part of our commitment to enhance efficiency and better serve our stakeholders.

New Location:

Engineering Corporation Building, No.130, W.A.D Ramanayake Mawatha, Colombo 02.

Divisions Relocated:

• Medicine Regulatory Division
• Medical Device Regulatory Division
• Borderline Regulatory Division
• Cosmetics Regulatory Division
• Manufacturing Regulatory Division
• Clinical Trial Regulatory Division
• Pharmacovigilance Division
• Pricing Unit

Operational Details:

• Dossier Acceptance and Letter Receiving/Issuing Counters will also operate in the new location.
• The National Medicines Quality Assurance Laboratory (NMQAL) will remain at its previous location on 120, Norris Canal Road, Colombo 10.

We kindly request all stakeholders to update their records and direct any correspondence to the new address.

Chief Executive Officer

National Medicines Regulatory Authority